Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Contact Email
Phone number
Website URL
Similar Companies995
Regentys
Regentys is a regenerative medicine company that develops treatments for gastrointestinal disorders..
Sector
Subsector
Location
total rounds
total raised
Actipulse Neuroscience (YC W22)
The company specializes in non-invasive brain stimulation technology for treating neurological and psychiatric diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Neuronetics
Neuronetics develops non-invasive therapies for psychiatric and neurological disorders.
Sector
Subsector
Keywords
Location
total rounds
total raised
Synergo
Synergo is a company that provides less invasive therapies for the treatment of bladder cancer.
Sector
Subsector
Keywords
Location
Financials
Funding Rounds10
Number of Funding Rounds
Money Raised
Their latest funding was raised on 03.06.2024. Their latest round Post-IPO Equity
Co-Investors
Investors6
Number of lead investors
Number of investors
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund is a healthcare venture capital firm that invests in innovative digital health companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Core Ventures Group
Core Ventures is a venture capital firm that invests in seed stage b2b companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Knoll Capital Management
Knoll Capital Management is a venture capital firm that invests in IT-focused companies.
Sector
Subsector
count Of Investments
count Of Exists
People
Founders5
Steve Mendez
Steve is a Research and Development executive with 28 years experience driving all phases of product life cycle from concept/patents and design to manufacturing and sales/field support. Previously Vice President of Development with the EBI division of Biomet, Steve was responsible for electronic, bracing, and softgood products in addition to overseeing the development of external and implantable electrical/thermal therapy medical devices. He also established and managed electronic production/test/repair departments at EBI and previous employers. Steve obtained an MSEE from Rensselaer Polytechnic Institute, and a BSEE and BA Biology from Lehigh University.
current job
organization founded
Steve Mendez
Thomas Errico
Errico is Chief of the Division of Spine Surgery in the Department of Orthopedics at NYU Langone Medical Center and NYU Langone Orthopedic Hospital. He is also a tenured Professor of Orthopedic and Neurological Surgery at NYU School of Medicine. His undergraduate degree was completed at Rutgers University. He then went on to graduate and complete an internship from what was then known as the University of Medicine and Dentistry of New Jersey. After completing a residency in Orthopedics at NYU School of Medicine, he completed a yearlong fellowship in spinal surgery at the University of Toronto under the direction of Dr. John Kostuik. Among others, Dr. Errico helped found K2M Group Holdings, Inc, which is now a public-traded company selling spinal implants. Dr. Errico has served as President of both the North American Spine Society (NASS) and the International Society for the Advancement of Spine Surgery (ISASS). Along with JP Errico, Dr. Errico founded several medical device companies. According to the Medicine Lodge 2001 Spinal Implant Intellectual Property Report, he is the most prolific inventor in the field of spinal implants. According to Becker's Orthopedic & Spine Review, Dr. Errico has been listed as one of 8 spinal surgeons to know in the field of scoliosis. He was also listed as one of the 10 best orthopedic surgeons in the US Health Articles 101. Dr. Errico also served on the Board of Directors of SpineCore, a company he co-founded, from inception to sale.
current job
organization founded
Thomas Errico
JP Errico
JP received his undergraduate degree in aeronautical engineering from the Massachusetts Institute of Technology, and worked at the Air Force National Laboratory, Lincoln Laboratories. He holds both law and mechanical/materials engineering graduate degrees from Duke University. JP trained as a patent attorney in New York, and is the author of a treatise on international intellectual property law. Along with fellow investor and Board Member, Dr. Thomas Errico, Mr. Errico has founded a number of medical device companies, including Fastenetix, K2 Medical, AD-4 Pharma, E2, and SpineCore. Products conceived by these companies have generated more than $8 billion in sales to date. He served as the CEO of SpineCore from the inception of the company through to its sale to Stryker in July 2004. JP is a named inventor on more than 125 issued US patents, and is a named inventor on more than 100 pending US applications. Additional patents and patent applications outside the US on which he is a named inventor number greater than 200. In addition to his current role as CEO, he continues also to make significant inventive contributions in all aspects of the company’s key patent portfolios, along with the clinical and market validations of the company’s products and their indications
current job
organization founded
JP Errico
Employee Profiles19
Renee Chioccariello
Director, marketing communications and sales force effectiveness
Jacquelyn Pinchuk
Director, strategic marketing and analytics
JP Errico
Co-Founder, Chief Science & Strategy Officer
Mindy Yang
Executive director, clinical development and medical affairs
Steve Mendez
Co-Founder and Chief Technical Officer